NVCR | | NovoCure Ltd | Leonard Frank X | EVP, Pres., Novocure Oncology | Mar 04, 2024 | Sale | $16.01 | 840 | 13,448 | 160,098 | Mar 05, 2024, 04:08 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | EVP, Pres., Novocure Oncology | Mar 01, 2024 | Sale | $16.03 | 1,679 | 26,909 | 160,938 | Mar 05, 2024, 04:08 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | EVP, Pres., Novocure Oncology | Feb 27, 2024 | Option Exercise | $16.30 | 102,249 | 1,666,659 | 164,695 | Feb 29, 2024, 04:38 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | EVP, Pres., Novocure Oncology | Feb 28, 2024 | Sale | $16.14 | 2,078 | 33,545 | 162,617 | Feb 29, 2024, 04:38 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Mar 03, 2023 | Sale | $76.16 | 5,291 | 402,959 | 63,490 | Mar 07, 2023, 04:52 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Mar 07, 2023 | Sale | $75.16 | 8,318 | 625,205 | 56,599 | Mar 07, 2023, 04:52 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Mar 03, 2023 | Sale | $77.64 | 2,059 | 159,859 | 67,893 | Mar 06, 2023, 04:37 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Mar 02, 2023 | Sale | $75.28 | 844 | 63,535 | 58,144 | Mar 06, 2023, 04:37 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Mar 02, 2023 | Sale | $75.38 | 4,107 | 309,578 | 59,296 | Mar 03, 2023, 04:13 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Mar 01, 2023 | Sale | $76.36 | 1,684 | 128,594 | 63,095 | Mar 02, 2023, 05:01 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Jan 05, 2023 | Sale | $66.60 | 74,716 | 4,976,351 | 53,984 | Jan 09, 2023, 06:21 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Oct 13, 2022 | Sale | $76.01 | 6,754 | 513,372 | 43,626 | Oct 17, 2022, 04:35 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Oct 06, 2022 | Sale | $84.37 | 6,754 | 569,835 | 50,380 | Oct 07, 2022, 04:16 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Sep 29, 2022 | Sale | $77.35 | 6,754 | 522,422 | 57,134 | Sep 30, 2022, 04:20 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | President, CNS Cancers US | Sep 22, 2022 | Sale | $77.00 | 6,754 | 520,058 | 63,888 | Sep 26, 2022, 04:19 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Sep 15, 2022 | Sale | $63.28 | 17,788 | 1,125,668 | 82,913 | Sep 19, 2022, 04:10 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Sep 08, 2022 | Sale | $81.48 | 6,754 | 550,316 | 77,396 | Sep 13, 2022, 04:15 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Sep 09, 2022 | Sale | $88.00 | 1,863 | 163,944 | 84,150 | Sep 12, 2022, 04:32 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Sep 06, 2022 | Sale | $78.57 | 1,384 | 108,741 | 86,013 | Sep 07, 2022, 04:27 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Sep 01, 2022 | Sale | $77.43 | 14,212 | 1,100,476 | 101,146 | Sep 06, 2022, 04:19 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Sep 02, 2022 | Sale | $79.04 | 584 | 46,158 | 87,397 | Sep 06, 2022, 04:19 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Aug 02, 2022 | Sale | $69.66 | 414 | 28,839 | 102,193 | Aug 03, 2022, 04:44 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Jul 05, 2022 | Option Exercise | $59.08 | 312 | 18,431 | 102,607 | Jul 07, 2022, 05:46 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Mar 08, 2022 | Sale | $70.10 | 744 | 52,154 | 102,295 | Mar 09, 2022, 04:55 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Mar 03, 2022 | Sale | $74.50 | 930 | 69,283 | 103,594 | Mar 07, 2022, 06:14 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Mar 04, 2022 | Sale | $70.41 | 555 | 39,076 | 103,039 | Mar 07, 2022, 06:14 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Sep 02, 2021 | Sale | $138.23 | 540 | 74,645 | 87,153 | Sep 07, 2021, 04:39 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Aug 03, 2021 | Sale | $149.43 | 328 | 49,013 | 89,158 | Aug 04, 2021, 05:20 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Aug 02, 2021 | Sale | $149.38 | 713 | 106,507 | 89,486 | Aug 04, 2021, 05:20 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Jul 06, 2021 | Option Exercise | $137.12 | 154 | 21,117 | 90,199 | Jul 08, 2021, 05:36 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Mar 08, 2021 | Sale | $130.81 | 765 | 100,067 | 90,045 | Mar 10, 2021, 04:07 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Mar 04, 2021 | Sale | $137.55 | 567 | 77,993 | 90,810 | Mar 08, 2021, 04:24 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Mar 02, 2021 | Sale | $152.05 | 430 | 65,383 | 82,668 | Mar 04, 2021, 05:55 PM |
NVCR | | NovoCure Ltd | Leonard Frank X | Chief Development Officer | Feb 27, 2021 | Option Exercise | $149.10 | 1,465 | 218,432 | 83,098 | Mar 02, 2021, 04:12 PM |